Stay updated with breaking news from 26815810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com lowered shares of Dynavax Technologies (NASDAQ:DVAX – Free Report) from a buy rating to a hold rating in a research note published on Friday. Several other research analysts have also recently weighed in on DVAX. The Goldman Sachs Group started coverage on Dynavax Technologies in a research note on Thursday, February 1st. They issued […]
Executive Wealth Management LLC acquired a new position in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 20,000 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. Several other hedge funds have also recently […]
E Fund Management Co. Ltd. boosted its stake in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 6.6% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 24,484 shares of the biopharmaceutical company’s stock after buying an additional 1,525 shares during the period. E Fund Management Co. Ltd.’s holdings in Dynavax Technologies were […]
Virtus ETF Advisers LLC decreased its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 9.1% during the third quarter, according to its most recent filing with the SEC. The firm owned 7,831 shares of the biopharmaceutical company’s stock after selling 785 shares during the period. Virtus ETF Advisers LLC’s holdings in […]
The Goldman Sachs Group began coverage on shares of Dynavax Technologies (NASDAQ:DVAX – Free Report) in a report published on Thursday morning, Marketbeat reports. The firm issued a neutral rating and a $20.00 price objective on the biopharmaceutical company’s stock. A number of other analysts also recently commented on DVAX. JMP Securities upped their target […]